dinitrochlorobenzene has been researched along with Carcinoma, Transitional Cell in 10 studies
Dinitrochlorobenzene: A skin irritant that may cause dermatitis of both primary and allergic types. Contact sensitization with DNCB has been used as a measure of cellular immunity. DNCB is also used as a reagent for the detection and determination of pyridine compounds.
1-chloro-2,4-dinitrobenzene : A C-nitro compound that is chlorobenzene carrying a nitro substituent at each of the 2- and 4-positions.
Carcinoma, Transitional Cell: A malignant neoplasm derived from TRANSITIONAL EPITHELIAL CELLS, occurring chiefly in the URINARY BLADDER; URETERS; or RENAL PELVIS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We have done a double-blind, randomized, controlled study on 37 patients with transitional cell carcinoma in which levamisole was used as an immune adjuvant in addition to the standard therapy for non-invasive and invasive bladder cancer." | 9.04 | Levamisole in the treatment of non-invasive and invasive bladder cancer: a preliminary report. ( Baron, B; Dekernion, J; Kaufman, JJ; Skinner, DG; Smith, RB, 1978) |
| "Sixty-two patients with transitional cell carcinoma have been admitted to a double-blind randomized control study with levamisole as an immune adjuvant, in addition to standard therapy for noninvasive and invasive bladder cancer." | 9.04 | Preliminary report of the use of levamisole in the treatment of bladder cancer. ( deKernion, J; Kaufman, JJ; Lincoln, B; Skinner, DG; Smith, RB, 1978) |
| "Levamisole has been shown to be easily administered and is well-tolerated, especially when compared to other immune adjuvants such as bacillus Calmette-Guerin or Corynebacterium parvum." | 6.64 | Preliminary report of the use of levamisole in the treatment of bladder cancer. ( deKernion, J; Kaufman, JJ; Lincoln, B; Skinner, DG; Smith, RB, 1978) |
| "Tumor recurrence seems to be rare in those patients who are initially DNCB-positive." | 6.64 | Preliminary report of the use of levamisole in the treatment of bladder cancer. ( deKernion, J; Kaufman, JJ; Lincoln, B; Skinner, DG; Smith, RB, 1978) |
| "We have done a double-blind, randomized, controlled study on 37 patients with transitional cell carcinoma in which levamisole was used as an immune adjuvant in addition to the standard therapy for non-invasive and invasive bladder cancer." | 5.04 | Levamisole in the treatment of non-invasive and invasive bladder cancer: a preliminary report. ( Baron, B; Dekernion, J; Kaufman, JJ; Skinner, DG; Smith, RB, 1978) |
| "Sixty-two patients with transitional cell carcinoma have been admitted to a double-blind randomized control study with levamisole as an immune adjuvant, in addition to standard therapy for noninvasive and invasive bladder cancer." | 5.04 | Preliminary report of the use of levamisole in the treatment of bladder cancer. ( deKernion, J; Kaufman, JJ; Lincoln, B; Skinner, DG; Smith, RB, 1978) |
| "Levamisole has been shown to be easily administered and is well-tolerated, especially when compared to other immune adjuvants such as bacillus Calmette-Guerin or Corynebacterium parvum." | 2.64 | Preliminary report of the use of levamisole in the treatment of bladder cancer. ( deKernion, J; Kaufman, JJ; Lincoln, B; Skinner, DG; Smith, RB, 1978) |
| "Tumor recurrence seems to be rare in those patients who are initially DNCB-positive." | 2.64 | Preliminary report of the use of levamisole in the treatment of bladder cancer. ( deKernion, J; Kaufman, JJ; Lincoln, B; Skinner, DG; Smith, RB, 1978) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 9 (90.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (10.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Simic, T | 1 |
| Mimic-Oka, J | 1 |
| Savic-Radojevic, A | 1 |
| Opacic, M | 1 |
| Pljesa, M | 1 |
| Dragicevic, D | 1 |
| Djokic, M | 1 |
| Radosavljevic, R | 1 |
| Jakse, G | 1 |
| Hofstädter, F | 1 |
| Märk, R | 1 |
| Johnson, DK | 1 |
| Pontes, JE | 1 |
| Izbicki, R | 1 |
| Pierce, JM | 1 |
| Bean, MA | 1 |
| Schellhammer, PS | 1 |
| Herr, HW | 1 |
| Pinsky, CM | 1 |
| Whitmore, WF | 1 |
| Smith, RB | 2 |
| Dekernion, J | 2 |
| Baron, B | 1 |
| Skinner, DG | 2 |
| Kaufman, JJ | 2 |
| Lincoln, B | 1 |
| Adolphs, HD | 2 |
| Steffens, L | 2 |
| Fahey, JL | 1 |
| Brosman, S | 1 |
| Dorey, F | 1 |
| Catalona, WJ | 1 |
| Smolev, JK | 1 |
| Harty, JI | 1 |
2 trials available for dinitrochlorobenzene and Carcinoma, Transitional Cell
| Article | Year |
|---|---|
Levamisole in the treatment of non-invasive and invasive bladder cancer: a preliminary report.
Topics: Aged; Antigens, Neoplasm; Carcinoma, Transitional Cell; Chemotaxis, Leukocyte; Clinical Trials as To | 1978 |
Preliminary report of the use of levamisole in the treatment of bladder cancer.
Topics: Carcinoma, Transitional Cell; Chemotaxis, Leukocyte; Clinical Trials as Topic; Dinitrochlorobenzene; | 1978 |
8 other studies available for dinitrochlorobenzene and Carcinoma, Transitional Cell
| Article | Year |
|---|---|
Glutathione S-transferase T1-1 activity upregulated in transitional cell carcinoma of urinary bladder.
Topics: Carcinoma, Transitional Cell; Dinitrochlorobenzene; Glutathione Transferase; Humans; Substrate Speci | 2005 |
Specific red cell adherence test and unspecific immune response in patients with superficial bladder cancer.
Topics: Aged; Carcinoma in Situ; Carcinoma, Transitional Cell; Chemotaxis, Leukocyte; Dinitrochlorobenzene; | 1981 |
Prophylaxis of FANFT induced bladder tumours in rats by intravesical DNCB instillation.
Topics: Administration, Topical; Animals; Carcinoma, Transitional Cell; Dinitrochlorobenzene; FANFT; Female; | 1980 |
Immunocompetence of patients with transitional cell carcinoma as measured by dinitrochlorobenzene skin tests and in vitro lymphocyte function.
Topics: Carcinoma, Transitional Cell; Concanavalin A; Dinitrochlorobenzene; Humans; In Vitro Techniques; Lym | 1978 |
Correlation between tumour stage, tumour grade, and immunocompetence in patients with carcinoma of the bladder and prostate.
Topics: Adenocarcinoma; Antibody Formation; Carcinoma, Transitional Cell; Dinitrochlorobenzene; Female; Huma | 1977 |
Evaluation of the immunocompetance of patients with transitional cell carcinoma of the bladder.
Topics: Adult; Aged; Antibody Formation; Carcinoma, Transitional Cell; Dinitrochlorobenzene; Drug Hypersensi | 1977 |
Immunological responsiveness in patients with bladder cancer.
Topics: Antigens; Carcinoma, Transitional Cell; Dinitrochlorobenzene; Humans; Hypersensitivity, Delayed; Imm | 1977 |
Prognostic value of host immunocompetence in urologic cancer patients.
Topics: Adenocarcinoma; Adult; Aged; Carcinoma, Transitional Cell; Dinitrochlorobenzene; Female; Follow-Up S | 1975 |